Peter Konrad to Antiparkinson Agents
This is a "connection" page, showing publications Peter Konrad has written about Antiparkinson Agents.
Connection Strength
0.461
-
Early subthalamic nucleus deep brain stimulation in Parkinson's disease reduces long-term medication costs. Clin Neurol Neurosurg. 2021 Nov; 210:106976.
Score: 0.186
-
Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease. J Parkinsons Dis. 2016; 6(1):125-31.
Score: 0.125
-
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease. Parkinsonism Relat Disord. 2015 Oct; 21(10):1177-83.
Score: 0.121
-
Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial. J Parkinsons Dis. 2015; 5(1):151-63.
Score: 0.029